The 4th International Conference on Lymphocyte Engineering (ICLE 2023) will take place on 12-14 September 2023 in Munich, Germany.

ICLE is a cornerstone conference for the latest advances in immune-gene therapy, where ground-breaking research in the field is presented along with innovative clinical practices and treatment. Join the 2023 edition as it brings together immunotherapy with cell and gene therapy to foster interdisciplinary collaborations, deepening the connection between basic and clinical research across related disease specialties.

ICLE 2023 will once again take place in Munich - home to the biggest European research hub in the field, the perfect location for the only international conference focusing specifically on research and clinical translation of gene therapy, cell therapy, genome engineering, and immunotherapy.

Great strides have been made in recent years in the engineering of lymphocytes for the treatment of cancer, autoimmune diseases, pathogenic diseases, and primary immune deficiencies. Combining gene therapy, cell therapy and immune therapy, the emerging field of lymphocyte engineering employs cutting-edge technologies of viral and non-viral vectorology, genome editing, and protein design as well as advanced clinical protocols for cell harvest, expansion, and re-infusion and for the exciting alternative of in vivo engineering. With groundbreaking clinical success leading to FDA-approved products and with vibrant, exponentially growing research, lymphocyte engineering is the wave of the future.

Still, the challenges are formidable, and the stakes are high. Realizing the full promise of lymphocyte engineering will require the combined efforts of a dedicated community. ICLE 2023 will facilitate the sharing of data and ideas, promote collaborations, and address common challenges to advance clinical translation. It will provide an effective environment for active learning, discussions of real-world case studies, and networking between like-minded peers. Learn what is done to translate the lymphocyte engineering research to clinical practice and how your colleagues overcome their challenges. Hear from renown leaders, sharing invaluable insights on lymphocyte engineering therapies and discuss the latest findings and trends.

Whether you are a scientist, clinical researcher, part of a start-up, or an established industry company, ICLE 2023 is your opportunity to network and discuss immuno-gene therapy with those as excited and passionate about this innovative treatment modality.

Read on kenes.com

Continue reading at lymphocyte.kenes.com

Hematology Oncology Allergy and Immunology

Facebook Share

Twitter Share

Linkedin Share

Email Share